Controversies related to the use of agents with a potential anticancer activity

Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 8

Abstract

Discoveries of antitumoral potential of commonly used, non-oncological drugs have appeared regularly in the medical journals all over the years. Information on such agents as statins, COX-2 inhibitors or inhibitors of ACE have been always widely discussed by oncologist. Despite numerous proofs of their antitumoral activity obtained from preclinical and retrospective cohort studies to date only few prospective, randomized clinical studies have been performed. Moreover, only few of these clinical studies have confirmed the expected prophylactic or therapeutic effect of the tested agents in relation to neoplastic diseases. Based on preclinical and retrospective cohort studies one assumes that ACE inhibitors impair development of experimental tumors and decrease the relative risk of cancer. The antitumoral mechanism of ACE inhibitors is believed to be associated with a blockade of proliferation and induction of apoptosis of tumor cells as well as with inhibition of neoangiogenesis. In our studies we have evaluated the effect of captopril (ACE inhibtor) on growth and development of immunogenic tumors in murine models of renal cell cancer (RenCa) and metylocholantrene-induced sarcoma (MehtA). Suprisingly, we have demonstrated that captopril promoted growth and metastatic potential of tumor cells and shortened the survival of tumor-bearing mice with an intact immune system. The observed effect was associated with an impairment of specific cellular anti-tumor responses mediated by cytotoxic T lymphocytes (CD8+). Our studies further confirm the common opinion that administration of drugs with a suspected anti-tumor activity must be based on tightly controlled, prospective and randomized clinical studies.

Authors and Affiliations

Piotr Wysocki, Andrzej Mackiewicz

Keywords

Related Articles

Cancer pain in children and adolescents

As far as population of growth age is concerned, every year, in Poland there are 1100 to 1300 new cases of going down with cancer. The most common cases are leukemia, tumour, lymphoma (59.3% of all children’s cancer ca...

The usefulness of tumour markers in the diagnostics of head and neck cancer patients

The dominating histological type among head and neck tumours is squamous cell carcinoma. This creates specific preferences in choosing tumour markers determined for diagnosing head and neck cancer patients. Due to their...

Aktywność N-acetylo-β-heksozoaminidazy i jej izoenzymów w tkance nerki, w surowicy krwi i w moczu pacjentów z rakiem nerki

W Polsce nowotwór nerki, obejmujący 3–4 proc. wszystkich nowotworów złośliwych, stanowi trudny problem diagnostyczny. Rak nerki (najczęstszy nowotwór nerki u dorosłych) jest zwykle diagnozowany, gdy wystąpiły odległe prz...

Effectiveness and toxicity of Interleukin 2, Interferon α, and 5-Fluorouracil in patients with Metastatic Renal Cell Cancer

Purpose: The purpose of this study was to evaluate the potential efficacy and toxicity for the treatment of metastatic renal cell cancer. Material and methods: During the first 4 weeks of treatment, patients rec...

Przezoskrzelowa ultrasonografia w diagnostyce chorób układu oddechowego

Przezoskrzelowa ultrasonografia (PU) jest metodą inwazyjną, stanowiącą uzupełnienie bronchofiberoskopii (BRF) i tomografii komputerowej (TK) w diagnostyce wybranych procesów chorobowych, przebiegających w obrębie klatki...

Download PDF file
  • EP ID EP144383
  • DOI -
  • Views 67
  • Downloads 0

How To Cite

Piotr Wysocki, Andrzej Mackiewicz (2006). Controversies related to the use of agents with a potential anticancer activity. Współczesna Onkologia, 10(8), 408-413. https://europub.co.uk./articles/-A-144383